You are seeing these quotes based on previous browsing related to sectors such as
| Latest | Forecast | |
|---|---|---|
| Div Yield | 0.0% | 0.0% |
| Div Cover | n/a | n/a |
| Op Mrgn | -50.7% | 9.9% |
| ROCE | 0.0% |
| Latest | Forecast | |
|---|---|---|
| P/E | -11.4 | 27.3 |
| PEG | 0.0 | -999,999.0 |
| Price / Revenue | 6.7 | 2.7 |
| Price / Book value | 6.2 |
| Latest | Forecast | |
|---|---|---|
| Revenue | 511.3% | -31.8% |
| PBT | 0.0% | n/a |
| EPS | 0.0% | -66.1% |
| DPS | n/a | 0.0% |
| Year Ending | Revenue (€m) |
Pre-tax (€m) |
EPS | P/E | PEG | EPS Growth | Div | Yield |
|---|---|---|---|---|---|---|---|---|
| 2017-12-31 | 17.41 | -1.80 | €-0.03 | -4.7 | 0.0 | n/a | n/a | 0.0% |
| 2018-12-31 | n/a | -1.66 | €-7.85 | 0.0 | 0.0 | n/a | n/a | 0.0% |
| 2019-12-31 | 3.37 | -5.81 | -3.48p | -1.3 | 0.0 | n/a | n/a | 0.0% |
| 2020-12-31 | 20.60 | -11.16 | -1.80p | -14.3 | 0.0 | n/a | n/a | 0.0% |
| Open Orphan signs £5m human flu study contract Sharecast News | 21 Dec |
|---|---|
| Open Orphan signs contract to test antiviral candidate Sharecast News | 10 Dec |
| Open Orphan subsidiary locks in £5.1m contract with biopharma firm Sharecast News | 17 Nov |
| £5m Influenza human challenge study contract win | 21-Dec-21 07:00 |
|---|---|
| Second Price Monitoring Extn | 16-Dec-21 16:42 |
| Price Monitoring Extension | 16-Dec-21 16:35 |
| Second Price Monitoring Extn | 10-Dec-21 11:05 |
| Price Monitoring Extension | 10-Dec-21 11:00 |